C Flamigni

No ORCID on file · 31 papers in corpus · active 1975-2005

Study types

  • article 24
  • review 3
  • other 2
  • book-chapter 1
  • erratum 1

Condition tags

  • endometriosis 21
  • mesh:D004715 7
  • infertility 3
  • mesh:D004412 3
  • dysmenorrhea 2
  • mesh:D004716 1
article 2005
Implantation markers and endometriosis
Reproductive biomedicine online ·doi:10.1016/s1472-6483(10)61142-x
article 2004
Half-dose depot triptorelin in pituitary suppression for multiple ovarian stimulation in assisted reproduction technology: a randomized study*
·doi:10.1093/humrep/deh415

BACKGROUND: Pituitary suppression by depot GnRH agonist may be excessive for ovarian stimulation in assisted reproduction technology. This study compares the efficacy of standard and half-dose depot triptorelin in a long protocol. METHODS: …

review 2004
The Patterns of Uterine Contractility in Normal Menstruating Women: From Physiology to Pathology
Annals of the New York Academy of Sciences ·doi:10.1196/annals.1335.007

The nonpregnant uterus shows uterine activity throughout the menstrual cycle. This uterine activity was detected both by single strep tissue and by using intrauterine pressure recordings in vitro and in vivo. Today, ultrasound has made it p…

article 2003
Psychological distress of conservative and nonconservative uterine surgery
·doi:10.1016/s0022-3999(02)00394-x
article 2003
Recurrence of endometriosis in women with abnormal uterine contractility
·doi:10.1016/s0015-0282(03)01500-0
article 2002
Characteristics of uterine contractility during menses in women with mild to moderate endometriosis
Fertility and Sterility ·doi:10.1016/s0015-0282(02)03087-x
article 2002
Endometriosis: absence of recurrence in patients after endometrial ablation
·doi:10.1093/humrep/17.3.844
article 2002
Endometriosis: Absence of Recurrence in Patients After Endometrial Ablation
·doi:10.1097/00006254-200206000-00019

Bulletti, Carlo; DeZiegler, Dominique; Stefanetti, Marco; Cincinelli, Ettore; Pelosi, Emanuele; Flamigni, Carlo

erratum 2002
Erratum: Endometriosis: Absence of recurrence in patients after endometrial ablation (Human Reproduction 16 (2676-2679))
article 2002
Twenty-One Day Administration of Dienogest Reversibly Suppresses Gonadotropins and Testosterone in Normal Men
·doi:10.1210/jcem.87.5.8514

Androgen-progestin combinations are promising male contraceptive regimens. Optimization of these regimens includes the development of new progestins with more favorable biological properties. In this context we tested the effects of the pro…

article 2001
Endometriosis: absence of recurrence in patients after endometrial ablation
Human Reproduction ·doi:10.1093/humrep/16.12.2676

BACKGROUND: The present study was undertaken to evaluate differences between patients with and without eutopic endometrium in the recurrence of ectopic endometriotic implants. METHODS: Endometrial ablation (EA) was carried out in 14 women o…

article 2000
Endometriosis. Absence of Recurrence Rate in Patients with Endometrial Ablation
·doi:10.1016/s0015-0282(00)01055-4
other 2000
Uterine contractility during the menstrual cycle
Human Reproduction ·doi:10.1093/humrep/15.suppl_1.81

The non-pregnant uterus shows different patterns of contractility during the menstrual cycle. A renewed interest in uterine contractility has resulted from reports of non-invasive ultrasound (US) based studies. To clarify the changes in ute…

article 1999
Endometriosis
·doi:10.1016/s1074-3804(99)80139-x
other 1997
Abnormal uterine contractility in nonpregnant women
Annals of the New York Academy of Sciences ·doi:10.1111/j.1749-6632.1997.tb48543.x
review 1996
Reproductive failure due to spontaneous abortion and recurrent miscarriage
Human reproduction update ·doi:10.1093/humupd/2.2.118

The epidemiology, aetiology, diagnosis and clinical management of spontaneous and recurrent abortion and of the failure of embryo implantation are discussed in a retrospective overview of the major studies conducted since 1975 identified th…

article 1996
The efficacy of drugs in the management of endometriosis
The Journal of the American Association of Gynecologic Laparoscopists ·doi:10.1016/s1074-3804(05)80157-4
article 1996
Uterine contractility in patients with endometriosis
The Journal of the American Association of Gynecologic Laparoscopists ·doi:10.1016/s1074-3804(96)80143-5
article 1995
Gamete intrafallopian transfer: prospective randomized comparison between hysteroscopic and laparoscopic transfer techniques
·doi:10.1016/s0015-0282(16)57735-8
article 1995
The use of danatrol and gonadotropin-releasing hormone analog in preparing women with endometriosis for surgical treatment
·doi:10.1016/s1074-3804(05)80469-4
article 1992
Treatment of hirsutism by an association of oral cyproterone acetate and transdermal 17β‐estradiol
·doi:10.1016/0020-7292(92)90408-b

Twenty-four hirsute women were treated with an inversal sequential scheme of cyproterone acetate, 50 mg/d by oral route from the 1st to the 15th day of the menstrual cycle, along with 100 micrograms/24 h of 17 beta-estradiol transdermally a…

article 1991
Gamete intrafallopian transfer by hysteroscopy as an alternative treatment for infertility
Fertility and Sterility ·doi:10.1016/s0015-0282(16)54547-6
article 1991
Tissue Factors Influencing Growth and Maintenance of Endometriosisa
Annals of the New York Academy of Sciences ·doi:10.1111/j.1749-6632.1991.tb37869.x

The unpredictable response of endometriosis to steroids and its recurrence after therapy, led us to hypothesize a possible further control of this pathology by factors other than steroids. The presence of estrogen, progesterone and epiderma…

article 1988
Danazol reverses endometrial hyperplasia to normal endometrium.

Danazol, an isoxazol derivate of ethinyltestosterone, was used in the treatment of thirtyone postmenopausal patients with endometrial hyperplasia at the dose of 400 mg/day for three months. A profound growth-inhibitory effect of danazol on …

review 1988
GnRH agonists and antagonists. Current clinical status
Drugs ·doi:10.2165/00003495-198835010-00004

Gonadotrophin-releasing hormone (GnRH) analogues offer a novel approach for the non-steroidal manipulation of the reproductive endocrine axis. GnRH agonists are now effectively employed in the management of precocious puberty, prostate and …